Home Artists Posts Import Register

Content

The first huge milestone is over, enough signatures were gathered to get this initiative on the ballot for a vote.  Oregon could become the first US state with regulated, statewide access to psilocybin therapy.  It will be interesting to see how much support the idea has come November and if proponents can educate the wider voting population in time.  It may be challenging without big budgets although there has been quite a lot of media coverage which may be enough to give the majority of voters a favorable and informed view.  This would be a very big development that could encourage other states to follow suit as was seen with the cannabis movement.  Congrats to all who helped spread the word and gathered signatures!

Files

Comments

GordoTEK

I'm all for legalizing plant medicines, but I do worry about the people who could be harmed by these substances too. If you look at the Hopkins research studies you will find that they excluded over 90% of volunteers. Who is going to be excluding people when access opens up to the public? Maybe no one, they could potentially even get sued for trying to exclude anyone. This might lead to "incidents" around psychosis triggered by psychedelics, and might also lead to things getting shut down again which might be counterproductive to the psychedelic movement. You already see problems like this with ayahuasca centers outside of the US (a handful of deaths, sexual abuse, incidents of psychosis that were not handled well, etc). I do like the cautious approach that Oregon is proposing, including training and certification for those offering these substances.

Jamie

Thanks for your balanced thoughts. I do feel that those in favor of the movement can’t be irrationally close-minded to the risks of these drugs that require so much respect. But, I’m torn down the middle because, while I want regulation for safety, I don’t want these drugs to end up being monopolized but pharmaceutical companies or other institutions. Don’t want to see these experiences become cost-prohibitive and inaccessible to some who need them. I don’t know how likely the this is, but drug prices in the US for things like insulin and epi-pens come to mind.